Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Recens Medical Inc. (394420)
Market Open
15 Oct, 06:30 AM
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
6,290.
00
-430
-6.3988%
₩
105.25B
Market Cap
-
P/E Ratio
-
Div Yield
68,014
Volume
-
Eps
₩
6,720
Previous Close
Watching
Watch
Add Transaction
Day Range
6,020
6,550
Year Range
6,020
39,900
Want to track
394420
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Statistics
Historical Data
Recens Medical Inc. (394420) Statistics
Valuation metrics
Market Cap
105.25B
Enterprise value
76.88B
Trailing P/E (ttm)
-3.36
Forward P/E
12.63
PEG ratio
0.04
Price/Sales (ttm)
13.35
Price/Book (mrq)
5.33
Enterprise Value/Revenue
10.12
Enterprise Value/EBITDA
-7.62
Overview
Shares outstanding
10.85M
Float
5.44M
Shares short
-
% Held by insiders
0.33%
% Held by institutions
0.12%
Average volume (10 days)
74.93K
Average volume (90 days)
125.82K
Price summary
52-Week low
6,020
52-Week high
39,900
Beta
-
50-Day moving average
12,201.4
200-Day moving average
18,678.27
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
30 Jun 2026
Profitability
Profit margin
-2.29%
Operating margin
-2.32%
Operational effectiveness
Return on assets
-1.59%
Return on equity
-2.74%
Income Statement
Revenue (ttm)
7.6B
Revenue per share (ttm)
939.91
Quarterly revenue growth (yoy)
-0.55%
Gross profit (ttm)
4.29B
EBITDA
-10.08B
Net income to common (ttm)
-17.38B
Diluted EPS (ttm)
-2,890
Quarterly earnings growth (yoy)
-0.25%
Balance Sheet
Total cash (mrq)
18.19B
Total cash per share (mrq)
1,954.55
Total debt (mrq)
6.18B
Total Debt/Equity (mrq)
29.35
Current ratio (mrq)
4.7%
Book value per share (mrq)
1,819.21
Cash Flow
Cash flow statement
-10.1B
Levered free cash flow (LFCF)
-19.12B